Technical Name Pharmaceutical Composition Against Influenza Virus Containing Sanguisorba officinalis L.
Project Operator National Defense Medical Center
Summary
The present invention relates to a pharmaceutical composition against influenza virus.  The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound.
Scientific Breakthrough
The present invention relates to a pharmaceutical composition against influenza virus.  The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound.
The present invention relates to a pharmaceutical composition against influenza virus. The pharmaceutical composition comprises a therapeutically effective amount of the extract of Sanguisorba officinalis L., or active compounds obtained from the extract of S. officinalis and the corresponding hydrolyzed compound.
Industrial Applicability
本發明提供全新選擇之藥物或健康食品,對於抗流感具有高效、毒性低、量產容易且成本低廉等優特點,適合國內生醫科技產業發展。
other people also saw